InvestorsHub Logo
Followers 65
Posts 23923
Boards Moderated 0
Alias Born 11/23/2016

Re: frrol post# 114174

Sunday, 08/06/2017 3:50:05 PM

Sunday, August 06, 2017 3:50:05 PM

Post# of 462557
Yes, that would be the drive of any Biotech, so long as they see some sliver of potential drug effect.

But, as has been debated (a lot) here, somewhat unusual, the PK/PD data has been listed by the company as an explicit catalyst up next. I just can't help, but think they are doing that because they really want to show a beautiful dose response curve at least for an identifiable subgroup, whence the time is right...but, I'd admit this notion may belong to the daydreaming category.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News